Pharmaceuticals

Global Antiglaucoma Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends

October 25, 2021 by The Business Research Company

The Global Antiglaucoma Drugs Market Report by The Business Research Company covers antiglaucoma drugs market drivers and restraints, antiglaucoma drugs market size, major players, and the impact of COVID-19 on the antiglaucoma drugs market.

The antiglaucoma drugs market consists of sales of antiglaucoma drugs and related services by entities (organizations, sole traders and partnerships) that produce antiglaucoma drugs to treat glaucoma conditions. Glaucoma is a group of eye conditions that lead to damage of the optic nerve of the eye causing blindness and impaired vision. Some of the major drugs include Xalantan, Lumigan, and Travatan among others.

The global antiglaucoma drugs market is expected to decline from $6,591.8 million in 2019 to $5,191.2 million in 2020 at a rate of -21.2%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 5.0% to $6,659.2 million in 2021 and reach $ 7,345.6 million in 2023 at a CAGR of 2.7%. The market is expected to reach $8,089.0 million in 2025 at a CAGR of 4.9% and $10,767.9 million in 2030 at a CAGR of 5.9%.

Increasing incidence and prevalence of glaucoma is expected to support the growth of the anti-glaucoma drugs market. Eye disorders such as glaucoma are becoming major causes of visual impairment and blindness globally. The increasing incidence and prevalence of glaucoma is expected to drive the anti-glaucoma drugs market.

Request A Sample For The Global Antiglaucoma Drugs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3522&type=smp

Some antiglaucoma drugs market trends include Rho-kinase inhibitors in glaucoma treatment. Rho-kinase inhibitors are different from widely used prostaglandin analogs because they target the outflow through trabecular meshwork rather than the uveoscleral outflow. Rho-kinase inhibitors have proved to decrease intraocular pressure by 25% to 30% with duration of action of 10 to 12 hours, which is more effective than the previous generation of drugs for this condition. Moreover, development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the anti-glaucoma drugs market. Combination therapy involves the use of more than one medication or drug to treat a disease.

Global antiglaucoma drugs market segments include:

1) By Product Type: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others

2) By Disease Condition: Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma

3) By Prescription Type: OTC Drugs, Prescription Drugs

4) By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Antiglaucoma Drugs Opportunities And Strategies: Forecast To 2030:

https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-market

The Antiglaucoma Drugs Opportunities And Strategies: Forecast To 2030 is one of a series of new reports from The Business Research Company that provides antiglaucoma drugs market overviews, analyzes and forecasts market size, share, antiglaucoma drugs market players, antiglaucoma drugs market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.

The antiglaucoma drugs identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More:

Read Antiglaucoma Drugs Opportunities And Strategies: Forecast To 2030 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Market Players Covered: Allergen PLC., Novartis AG, Santen Pharmaceutical Co., Ltd., Akorn, Pfizer

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Antiglaucoma Drugs Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.

Opportunities For Companies In The Antiglaucoma Drugs Sector: The report reveals where the global industry will put on most $ sales up to 2023.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at www.thebusinessresearchcompany.com

Here is a list of reports from The Business Research Company similar to the Antiglaucoma Drugs Opportunities And Strategies: Forecast To 2030:

Dry Eye Medication Market

Ophthalmology Drugs Market

Vision Care Devices And Equipment Global Market Report 2021

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/